Full Name
Huay Cheem Tan
Variants
Tan, Huay-Cheem
Tan, Huay-Cheem
Tan, H.C.
Tan Huay Cheem
Tan, Huay Cheem
Tan, Huay Chweem
Tan, Huay Cheem
Cheem, T.H.
Tan, H.-C.
 
Main Affiliation
 
 
Email
mdcthc@nus.edu.sg
 

Publications

Results 121-129 of 129 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
12115-Oct-2006Twelve-Month Outcomes With a Paclitaxel-Eluting Stent Transitioning from Controlled Trials to Clinical Practice (the WISDOM Registry)Abizaid, A.; Chan, C.; Lim, Y.-T. ; Kaul, U.; Sinha, N.; Patel, T.; Tan, H.-C. ; Lopez-Cuellar, J.; Gaxiola, E.; Ramesh, S.; Rodriguez, A.; Russell, M.E.
22008Two Years Clinical Registry Follow Up of Endothelial Progenitor Cell Capture Stent versus Sirolimus-Eluting Bioabsorbable Polymer-Coated Stent versus Bare Metal Stents in Patients Undergoing Primary Percutaneous Coronary Intervention for ST Elevation Myocardial InfarctionChong, E.; Shen, L. ; Soon, C.Y.; Ong, H.Y.; Poh, K.K. ; Teo, S.G.; Lee, C.-H. ; Low, A. ; Tan, H.C. 
32010Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction: ACUTE CORONARY SYNDROMEChong, E.; Poh, K.K. ; Lee, R.C.-H. ; Low, A. ; Teo, S.-G.; Tan, H.C. ; Liang, S.
42007Two-Year Outcome after Implantation of a Novel Drug-Eluting Stent using Bioabsorbable-Polymer Technology in Myocardial InfarctionTin, Hay E.; Hou, X. M.; Lim, J.; Low, A. ; Loke, C.; Tan, H.C. ; Lee, C.-H. 
5Feb-2006Update on drug-eluting stents for prevention of restenosisLee, C.-H. ; Tan, H.-C. ; Lim, Y.-T. 
62008Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: Intermediate- to long-term clinical follow-upCo, M.; Tay, E.; Lee, C.H. ; Poh, K.K.; Low, A. ; Lim, Y.T. ; Tan, H.C. ; Lim, J.; Lim, I.H.
72011Utilisation of emergency medical service among Singapore patients presenting with ST-segment elevation myocardial infarction: Prevalence and impact on ischaemic timeTan, L.-L.; Wong, H.-B.; Poh, C.-L.; Chan, M.Y.; Seow, S.-C. ; Yeo, T.-C. ; Teo, S.-G. ; Ooi, S.B.S.; Tan, H.-C. ; Lee, C.-H. 
84-Apr-2022Ventricular tachycardia from myocarditis following COVID-19 vaccination with tozinameran (BNT162b2, Pfizer-BioNTech)Lin, Weiqin ; Yip, Alfred Chung Lum; Evangelista, Lauren Kay Mance; Wong, Raymond Ching Chiew; Tan, Huay Cheem ; Lim, Toon Wei ; Singh, Devinder 
92016Visit-to-visit variability in LDL- and HDL-cholesterol is associated with adverse events after ST-segment elevation myocardial infarction: A 5-year follow-up studyBoey, E.; Gay, G.M.W. ; Poh, K.-K. ; Yeo, T.-C. ; Tan, H.-C. ; Lee, C.-H.